Search 

We want to improve the quality of life for 660.000 epilepsy families. (# is the western world only)

We want to give New Freedom and Peace of Mind to patients, parents, and health care professionals.

IctalCare A/S develops and markets a body-worn wireless epilepsy seizure alarm that help people with epilepsy, caregivers and healthcare professional

IctalCare 365 consist of a;
- Disposable electrode
- Reusable detector "Senses"
- Reusable A-Unit (receiver and transmitter)

Timeline;
- Launch 12.12.12 at 12.12 pm in Denmark
- Launch 12th of April 2013 in UK and Germany
- Launch 12th of April 2014 in USA
- Exit 2016

Finance;
- Expected revenue in 2016 is € 23 Million
- Positive cash flow from 2014 - 2015
- Expected EBITDA is € 9.3 Million in 2016 having a gross Margin of 55 %

Business Model
We have Sustainable Competitive Advantage using the Razor blade Model. The disposable electrodes secures a continuous sale and only IctalCare electrodes fit to the reusable "Senses" detector.

The Business Model is designed around a monthly subscription Model however buy on demand will also be possible

The Elektrodress is a revolutionary body suit that increases the mobility and abilities for people with Cerebral Palsy or stroke. Inerventions AB was founded in 2010, based on the innovation Elektrodress. Inerventions has an accumulated turn over of 7,5MSEK in mid 2012, and roughly 330 patients using the treatment system. In november 2012 we will be finished with the regulatory requirements and start product sales on the Scandinavian Market.

Partner&distributor arrangement in Japan

We are looking for new innovative medtech products&solutions for the Japanese market.

Innomedica is an international business development company specialized in licensing, distributor search and strategic planning. We provide our services to  medical technology, biotechnology and health product companies in Europe and Japan.

The Japan market is the world’s second largest healthcare market after USA. Japan has a 130 millon population with one of the highest GDP’s in the world. And all citizens are covered by national health insurance.

Japan Market in numbers

• 250 000 doctors
• close to 10 000 hospitals (> 20 beds/hospital)
• 100 000 clinics
• Pharmaceutical sales $115 billion in 2011
• Medical device annual sales $24 billion
• IVD annual sales $3,5 billion
• 80% of medical facilities are privately owned
• Half of the medical devices available in Europe and USA are not available in Japan

Innomedica supports companies in following business operations:

• Tailor-made distribution arrangement and partnering operations
• Market analysis
• Strategic planning
• Business development
• Partner candidate screening
• Introduction and marketing meetings
• Negotiation support
• Agreement process
• Marketing communication
• PR
• Academic collaborations
• Translations
• Project management

Inven2 is the TTO of the University of Oslo and Oslo University Hospital. Inven2 commercializes annually 25-30 inventions through license deals and creating start-ups. 75 % of the commercializations are within Life Science sector.

Invest in Skåne is the official inward investment agency for Skåne. Our mission is to promote international investment and trade in Southern Sweden. We help with partnerships and assist businesses in getting access to new markets. We pursue our mission by facilitating contacts with international corporations, and by promoting the Life Science expertise already present in the region.

With several years of experience in business development and life science, our team will assist your company in a simple 4-step process:

1. We define your business and partnership goals and determine what technology, products and competencies you are looking for.
2. We identify local companies, academic institutions and CMOs/CROs in your field highlighting potential business opportunities.
3. We arrange a visiting programme where you can initiate explorative discussions with prospective business partners.
4. We will support your efforts to successfully complete your partnership or investment project.